Company Profile
and short Details:
SANOFI,
A GLOBAL LIFE SCIENCES COMPANY
Sanofi
is a global life sciences company committed to improving access to healthcare
and supporting the people we serve throughout the continuum of care. From
prevention to treatment, Sanofi transforms scientific innovation into
healthcare solutions, in human vaccines, rare diseases, multiple sclerosis,
oncology, immunology, infectious diseases, diabetes and cardiovascular
solutions and consumer healthcare. More than 100,000 people at Sanofi are
dedicated to make a difference on patients’ daily life, wherever they live and
enable them to enjoy a healthier life.
INNOVATION
Research
starts by understanding science and transforming progress, into medical
innovations that meet patients’ needs. To achieve this and facing the
complexity of human diseases, we leverage our in-house skills and collaborate
with the wider scientific community.
In
2015, we launched 3 pioneer treatments:
Toujeo®
(Insulin glargine 300 U/ml) in diabetes
Praluent®
(alirocumab)1 against hypercholesterolemia
Dengvaxia®,
the first ever vaccine against dengue fever
We
expect to have 3 more major launches by 2020 in the field of asthma and atopic
dermatitis (dupilumab), rheumatoid arthritis (sarilumab), and diabetes
(Lixilan).
No comments:
Post a Comment